Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Cholesterol Medicines:Side Effects May Outweigh Benefits

MEDIA RELEASE                                                                         

3 JUNE 2013

Cholesterol-lowering Medicines In Elderly People: Side Effects May Outweigh Benefits

At least four in every ten Australians over the age of 65 are taking a cholesterol-lowering medicine, with statins such as atorvastatin, simvastatin and rosuvastatin the most commonly prescribed. However, according to an article in the June edition of Australian Prescriber, the risk of side effects in frail elderly people may outweigh the benefits of continuing on a statin.

Associate Professor Sarah Hilmer and Dr Danijela Gnjidic of the University of Sydney say that statins lower the chance of a heart attack or death in older people who have already had a heart attack. However, the benefit of statins in older people who do not already have heart disease is less clear.

“Statins can cause side effects, and these are more likely in people aged over 70, especially those taking several other medicines,” write the authors.

“Muscle pain or muscle damage are the most common side effects that cause people to stop treatment. Statins can also cause liver problems,” said the authors.

“Statins have also been found to contribute to memory loss or confusion in some people. This side effect may be reversed when statins are stopped.”

NPS MedicineWise clinical adviser Dr Philippa Binns says that it is important that people who have questions or concerns about their medicines talk to their doctor to get personalised advice.

“The benefits of a medicine must always be balanced against the harms,” says Dr Binns.

“It’s also natural that your priorities and your ability to tolerate a medicine may change over time. What’s important is that you don’t stop taking your medicine without consulting your doctor.”

To read the full article and others visit www.australianprescriber.com

People with questions about their medicine can call the NPS Medicines Line (1300 MEDICINE or 1300 633 424), Monday to Friday 9am to 5pm AEST.

ENDS.

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Onetai Station: Overseas Investment Office Puts Ceol & Muir On Notice

The Overseas Investment Office (OIO) has issued a formal warning to Ceol & Muir and its owners, Argentinian brothers Rafael and Federico Grozovsky, for failing to provide complete and accurate information when they applied to buy Onetai Station in 2013. More>>

ALSO:

Tomorrow, The UN: Feds President Takes Reins At World Farming Body

Federated Farmers president Dr William Rolleston has been appointed acting president of the World Farmers’ Organisation (WFO) at a meeting in Geneva overnight. More>>

ALSO:

I Sing The Highway Electric: Charge Net NZ To Connect New Zealand

BMW is turning Middle Earth electric after today announcing a substantial contribution to the charging network Charge Net NZ. This landmark partnership will enable Kiwis to drive their electric vehicles (EVs) right across New Zealand through the installation of a fast charging highway stretching from Kaitaia to Invercargill. More>>

ALSO:

Watch This Space: Mahia Rocket Lab Launch Site Officially Opened

Economic Development Minster Steven Joyce today opened New Zealand’s first orbital launch site, Rocket Lab Launch Complex 1, on the Mahia Peninsula on the North Island’s east coast. More>>

Earlier:

Marketing Rocks!
Ig Nobel Award Winners Assess The Personality Of Rocks

A Massey University marketing lecturer has received the 2016 Ig Nobel Prize for economics for a research project that asked university students to describe the “brand personalities” of three rocks. More>>

ALSO:

Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news